SHC (Sotera Health Co) NonCurrent Deferred Liabilities: $92 Mil (As of Mar. 2026)


SHC Sotera Health Co SHC
74 GF Score
Price $17.93
GF Value $16.33
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Sotera Health Co NonCurrent Deferred Liabilities?

Sotera Health Co SHC +1.01% 74 NonCurrent Deferred Liabilities is $92 Mil as of Mar. 2026. GuruFocus rates SHC with a GF Score™ of 74/100 and a GF Value™ of $16.33 (Fairly Valued). The stock has 4 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Sotera Health Co's non-current deferred liabilities for the quarter that ended in Mar. 2026 was $92 Mil.

Sotera Health Co NonCurrent Deferred Liabilities Related Terms

Sotera Health Co NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for Sotera Health Co's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sotera Health Co NonCurrent Deferred Liabilities Chart

Sotera Health Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 155.25 86.93 83.22 86.28 88.13

Sotera Health Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.37 65.47 71.25 88.13 91.69
SHC
74GF Score
Sotera Health Co SHC
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of $92 Mil mean?
Sotera Health Co (SHC) has a NonCurrent Deferred Liabilities of $92 Mil as of Mar. 2026. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Sotera Health Co and its competitors.
Is Sotera Health Co's NonCurrent Deferred Liabilities too high?
Sotera Health Co's current NonCurrent Deferred Liabilities is $92 Mil. Overall, Sotera Health Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sotera Health Co's NonCurrent Deferred Liabilities compare to VCYT and RDNT?
Sotera Health Co's NonCurrent Deferred Liabilities of $92 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Medical Diagnostics & Research company?
A good NonCurrent Deferred Liabilities depends on the Medical Diagnostics & Research industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on Sotera Health Co and its competitors. Sotera Health Co's current NonCurrent Deferred Liabilities is $92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sotera Health Co stock overvalued right now?
Based on GuruFocus' analysis, Sotera Health Co (SHC) is currently considered Fairly Valued. The stock's GF Value™ is $16.33, compared to a current price of $17.93 — trading 9.8% above its estimated fair value. The current NonCurrent Deferred Liabilities is $92 Mil. Sotera Health Co's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For Sotera Health Co (SHC), the current NonCurrent Deferred Liabilities is $92 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sotera Health Co (SHC) Overvalued in 2026?

Based on GuruFocus' analysis, Sotera Health Co stock appears to be overvalued. The current stock price of $17.93 is trading 9.8% above its estimated GF Value™ of $16.33. GuruFocus considers Sotera Health Co to be Fairly Valued.

Key valuation signals for SHC:

  • NonCurrent Deferred Liabilities: $92 Mil
  • GF Value™: $16.33 vs. price of $17.93 (9.8% above fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the SHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sotera Health Co Business Description

Address 9100 South Hills Boulevard, Suite 300, Broadview Heights, OH, USA, 44147
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.
74GF Score

Get the complete analysis for SHC

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.93
Price
$16.33
GF Value